← Back to Search

Acute Exercise for Spinal Cord Injury

N/A
Waitlist Available
Led By Wenjie Ji, MS
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Spinal cord injury group: Neurological level of injury C6 or below
Non-injured controls: Males or females without SCI
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during head-up tilt post the 20-min acute exercise
Awards & highlights

Study Summary

This trial is investigating whether individuals with spinal cord injury have more cardiac, cerebrovascular, and cognitive dysfunction than non-injured people, and if one session of moderate aerobic exercise can improve these functions.

Who is the study for?
This trial is for individuals aged 18-55, with or without spinal cord injury (SCI) at C6 level or below. Participants must understand English and be able to have certain brain blood flow signals detected. Excluded are those with color blindness, pregnancy, cardiovascular/respiratory diseases, diabetes, glaucoma, ADHD or other conditions affecting the cardiac nervous system.Check my eligibility
What is being tested?
The study tests if one session of moderate-intensity aerobic exercise can improve heart control functions, brain blood flow and thinking abilities in people with SCI compared to non-injured individuals during rest and specific physical tests.See study design
What are the potential side effects?
While not explicitly stated in the provided information, potential side effects may include typical risks associated with moderate exercise such as muscle soreness, fatigue or shortness of breath especially relevant for participants with SCI.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My spinal cord injury is at level C6 or lower.
Select...
I do not have a spinal cord injury.
Select...
I am between 18 and 55 years old and have not been injured.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during head-up tilt post the 20-min acute exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and during head-up tilt post the 20-min acute exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cardiac parasympathetic function
Cardiac sympathetic function
Cerebral oxygenation level
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SCIExperimental Treatment1 Intervention
Individuals with spinal cord injury
Group II: CONActive Control1 Intervention
Age-and sex-matched healthy controls with exercise intervention

Find a Location

Who is running the clinical trial?

State University of New York at BuffaloLead Sponsor
246 Previous Clinical Trials
49,478 Total Patients Enrolled
Wenjie Ji, MSPrincipal InvestigatorUniversity at Buffalo
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

One bout of moderate-intensity sub-maximal aerobic exercise Clinical Trial Eligibility Overview. Trial Name: NCT05542238 — N/A
Spinal Cord Injury Research Study Groups: SCI, CON
Spinal Cord Injury Clinical Trial 2023: One bout of moderate-intensity sub-maximal aerobic exercise Highlights & Side Effects. Trial Name: NCT05542238 — N/A
One bout of moderate-intensity sub-maximal aerobic exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05542238 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are the criteria for joining this research project within my grasp?

"This research requires 10 participants aged between 18 and 55 that are living with cerebrovascular disorders. Additionally, they must meet the International Standard for Neurological Classification of SCI (ISNCSCI) A-D criteria, have a neurological level of injury C6 or lower, be proficient in English, and possess the ability to detect middle cerebral artery blood velocity (MCAv) and/or posterior cerebral artery blood velocity (PCAv) signals through TCD."

Answered by AI

Is this research endeavor presently open to new participants?

"The current clinical trial is not accepting any new patients, according to information hosted on Clinicialtrials.gov. This medical research was first announced in September 6th 2022 and last updated 3 weeks later. Fortunately, there are 1076 other studies actively looking for participants at this moment."

Answered by AI

Is geriatric recruitment being conducted for this experiment?

"The age criteria for this trial requires that participants be between 18 and 55 years of age."

Answered by AI
~4 spots leftby Jun 2025